These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 23768737

  • 21. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study.
    Tsai CH, Liao LY, Lin CL, Chung WS.
    Clin Respir J; 2018 May; 12(5):1830-1837. PubMed ID: 29148205
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS.
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [Abstract] [Full Text] [Related]

  • 26. Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females.
    Kajiwara A, Kita A, Saruwatari J, Morita K, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
    J Asthma; 2014 Mar; 51(2):221-4. PubMed ID: 24147582
    [Abstract] [Full Text] [Related]

  • 27. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW.
    Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
    [Abstract] [Full Text] [Related]

  • 28. Impact of inhaled corticosteroid treatment on 15-year longitudinal respiratory function changes in adult patients with bronchial asthma.
    Shimoda T, Obase Y, Kishikawa R, Iwanaga T.
    Int Arch Allergy Immunol; 2013 Mar; 162(4):323-9. PubMed ID: 24193229
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
    Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 33. Risk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: a case-crossover study.
    Lee CH, Jang EJ, Hyun MK, Lee NR, Kim K, Yim JJ.
    Respirology; 2013 Oct; 18(7):1116-27. PubMed ID: 23711281
    [Abstract] [Full Text] [Related]

  • 34. The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease.
    Yamanashi K, Marumo S, Shoji T, Fukui T, Sumitomo R, Otake Y, Sakuramoto M, Fukui M, Huang CL.
    Gen Thorac Cardiovasc Surg; 2015 Dec; 63(12):652-9. PubMed ID: 26419246
    [Abstract] [Full Text] [Related]

  • 35. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T, Smith MA, Camp PG, Carleton BC.
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
    [Abstract] [Full Text] [Related]

  • 36. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
    Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M.
    J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
    [Abstract] [Full Text] [Related]

  • 37. Use of Inhaled Corticosteroids and the Risk of Lung Cancer, the HUNT Study.
    Sørli K, Thorvaldsen SM, Hatlen P.
    Lung; 2018 Apr; 196(2):179-184. PubMed ID: 29427221
    [Abstract] [Full Text] [Related]

  • 38. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 39. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Aug 10; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 40. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study).
    Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L.
    Pharmacoepidemiol Drug Saf; 2004 Aug 10; 13(8):569-79. PubMed ID: 15317039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.